TABLE 5.
Review of the Largest Series of MCNs (>30 Patients) Published From 1990 to Present
| Study | Yr | No. Patients | Ovarian Stroma (%) | Age (yr) | Female (%) | Distal Lesions (%) | Invasive Cancer (%) | Mean Tumor Size (cm) |
|---|---|---|---|---|---|---|---|---|
| Group A | ||||||||
| Zamboni et al1 | 1999 | 56 | 86 | 45 | 100 | 93 | 27 | 8.4 |
| Thompson et al5 | 1999 | 130 | 100 | 45 | 100 | 94 | 36 | 10.5 |
| Izumo et al9 | 2003 | 34 | 100 | 44 | 100 | 100 | 3 | 8.4 |
| Kosmahl et al10 | 2004 | 32 | 100 | 47 | 100 | 84 | 44* | 9.8 |
| Reddy et al3 | 2004 | 56 | 100 | 48 | 98 | 94 | 7 | 5 |
| Present series | 2006 | 163 | 100 | 45 | 95 | 97 | 12 | 5.5 |
| Group B | ||||||||
| Warshaw et al12 | 1990 | 42 | Not reported | 59 | 76 | 52 | 15 | 5 |
| Le Borgne et al13 | 1999 | 228 | Not reported | 50 | 78 | 53 | 6 | 6 |
| Sarr et al14 | 2000 | 84 | Not reported | 48 | 83 | 78 | 8 | |
| Willentz et al8 | 1999 | 61 | Not reported | 49 | 70.5 | 57 | 33 | 4 |
| Suzuki et al11 | 2004 | 179 | 73 | 56 | 100 | 72 | 31* | 5.9 |
Group A included studies where the presence of ovarian stroma was a diagnostic criteria for MCN, whereas in Group B studies it was not mandatory for MCN diagnosis.
Including invasive carcinoma and carcinoma in situ.